These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Mikasova L; De Rossi P; Bouchet D; Georges F; Rogemond V; Didelot A; Meissirel C; Honnorat J; Groc L Brain; 2012 May; 135(Pt 5):1606-21. PubMed ID: 22544902 [TBL] [Abstract][Full Text] [Related]
25. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. Steiner J; Walter M; Glanz W; Sarnyai Z; Bernstein HG; Vielhaber S; Kästner A; Skalej M; Jordan W; Schiltz K; Klingbeil C; Wandinger KP; Bogerts B; Stoecker W JAMA Psychiatry; 2013 Mar; 70(3):271-8. PubMed ID: 23344076 [TBL] [Abstract][Full Text] [Related]
30. Psychiatric Autoimmunity: N-Methyl-D-Aspartate Receptor IgG and Beyond. Kruse JL; Lapid MI; Lennon VA; Klein CJ; Toole OO; Pittock SJ; Strand EA; Frye MA; McKeon A Psychosomatics; 2015; 56(3):227-41. PubMed ID: 25975857 [TBL] [Abstract][Full Text] [Related]
31. N-Methyl-d-aspartate receptor autoantibodies in schizophrenia and affective disorders. Steiner J; Bogerts B Schizophr Res; 2015 Mar; 162(1-3):291. PubMed ID: 25600550 [No Abstract] [Full Text] [Related]
32. Response to Steiner and Bogerts on N-methyl-d-aspartate receptor autoantibodies in schizophrenia and affective disorders. Pearlman DM; Najjar S Schizophr Res; 2015 Mar; 162(1-3):292-3. PubMed ID: 25660466 [No Abstract] [Full Text] [Related]
33. Bipolar disorder and antibodies against the N-methyl-d-aspartate receptor: A gate to the involvement of autoimmunity in the pathophysiology of bipolar illness. León-Caballero J; Pacchiarotti I; Murru A; Valentí M; Colom F; Benach B; Pérez V; Dalmau J; Vieta E Neurosci Biobehav Rev; 2015 Aug; 55():403-12. PubMed ID: 26014349 [TBL] [Abstract][Full Text] [Related]
34. Acute psychosis due to non-paraneoplastic anti-NMDA-receptor encephalitis in a teenage girl: Case report. Kramina S; Kevere L; Bezborodovs N; Purvina S; Rozentals G; Strautmanis J; Viksna Z Psych J; 2015 Dec; 4(4):226-30. PubMed ID: 26663628 [TBL] [Abstract][Full Text] [Related]
35. Antibodies against N-Methyl D-Aspartate Receptor in Psychotic Disorders: A Systematic Review. Murashko AA; Pavlov KA; Pavlova OV; Gurina OI; Shmukler A Neuropsychobiology; 2022; 81(1):1-18. PubMed ID: 34000730 [TBL] [Abstract][Full Text] [Related]
36. NMDAR antibodies in patients with psychosis. Finke C Lancet Psychiatry; 2021 Feb; 8(2):88-89. PubMed ID: 33357498 [No Abstract] [Full Text] [Related]
37. NMDA and AMPA Receptor Autoantibodies in Brain Disorders: From Molecular Mechanisms to Clinical Features. Gardoni F; Stanic J; Scheggia D; Benussi A; Borroni B; Di Luca M Cells; 2021 Jan; 10(1):. PubMed ID: 33466431 [TBL] [Abstract][Full Text] [Related]
38. Alteration of NMDA receptor trafficking as a cellular hallmark of psychosis. Espana A; Seth H; Jézéquel J; Huang T; Bouchet D; Lepleux M; Gréa H; Bechter K; Schneider M; Hanse E; Groc L Transl Psychiatry; 2021 Aug; 11(1):444. PubMed ID: 34462417 [TBL] [Abstract][Full Text] [Related]
39. Autoantibodies in movement and psychiatric disorders: updated concepts in detection methods, pathogenicity, and CNS entry. Sinmaz N; Amatoury M; Merheb V; Ramanathan S; Dale RC; Brilot F Ann N Y Acad Sci; 2015 Sep; 1351():22-38. PubMed ID: 26083906 [TBL] [Abstract][Full Text] [Related]
40. Acute psychosis associated with anti-NMDA-receptor antibodies and bilateral ovarian teratomas: a case report. Fawcett RG J Clin Psychiatry; 2010 Apr; 71(4):504. PubMed ID: 20409449 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]